Literature DB >> 19728309

PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta.

Dorothée Duluc1, Fang Tan, Mari Scotet, Simon Blanchard, Isabelle Frémaux, Erwan Garo, Branka Horvat, Pierre Eid, Yves Delneste, Pascale Jeannin.   

Abstract

NK lymphocytes and type I IFN (IFN-alpha/beta) are major actors of the innate anti-viral response that also influence adaptive immune responses. We evaluated type I IFN production by human NK cells in response to polyI:C, a potent type I IFN-inducing TLR3 agonist. PolyI:C plus IL-2/IL-12 induced IFN-beta (but not IFN-alpha) mRNA expression and protein production by highly pure human NK cells and by the human NK cell line NK92. Neutralizing anti-IFNAR1 or anti-IFN-beta Ab prevented the production of IFN-gamma induced by polyI:C plus IL-2/IL-12. Similarly, IFN-gamma production induced by polyI:C plus IL-12 was reduced in NK cells isolated from IFNAR1(-/-) compared with WT mice. The ability of polyI:C plus IL-12 to induce IFN-gamma production was related to an increase of TLR3, Mda5 and IFNAR expression and by an increase of STAT1 and STAT4 phosphorylation. Collectively, these data demonstrate that NK cells, in response to polyI:C plus IL-2/IL-12, produce IFN-beta that induce, in an autocrine manner, the production of IFN-gamma and thereby highlight that NK cells may control the outcome of protective or injurious immune responses through type I IFN secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728309     DOI: 10.1002/eji.200838610

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing.

Authors:  Samantha L Smith; Philippa R Kennedy; Kevin B Stacey; Jonathan D Worboys; Annie Yarwood; Seungmae Seo; Everardo Hegewisch Solloa; Brandon Mistretta; Sujash S Chatterjee; Preethi Gunaratne; Kimaada Allette; Ying-Chih Wang; Melissa Laird Smith; Robert Sebra; Emily M Mace; Amir Horowitz; Wendy Thomson; Paul Martin; Steve Eyre; Daniel M Davis
Journal:  Blood Adv       Date:  2020-04-14

2.  SCID pigs: An emerging large animal NK model.

Authors:  Ellis J Powell; Joan E Cunnick; Christopher K Tuggle
Journal:  J Rare Dis Res Treat       Date:  2017-04-18

3.  Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.

Authors:  Jun Wu; Shunmei Huang; Xiaoli Zhao; Mingfa Chen; Yong Lin; Youchen Xia; Chan Sun; Xuecheng Yang; Junzhong Wang; Yan Guo; Jingjiao Song; Ejuan Zhang; Baoju Wang; Xin Zheng; Joerg F Schlaak; Mengji Lu; Dongliang Yang
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice.

Authors:  Timea Csak; Angela Dolganiuc; Karen Kodys; Bharath Nath; Jan Petrasek; Shashi Bala; Dora Lippai; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-05-02       Impact factor: 17.425

5.  Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.

Authors:  Nicholas A Young; Lai-Chu Wu; Craig J Burd; Alexandra K Friedman; Benjamin H Kaffenberger; Murugesan V S Rajaram; Larry S Schlesinger; Hayley James; Margaret A Shupnik; Wael N Jarjour
Journal:  Clin Immunol       Date:  2014-01-24       Impact factor: 3.969

6.  NK cells are intrinsically functional in pigs with Severe Combined Immunodeficiency (SCID) caused by spontaneous mutations in the Artemis gene.

Authors:  Ellis J Powell; Joan E Cunnick; Susan M Knetter; Crystal L Loving; Emily H Waide; Jack C M Dekkers; Christopher K Tuggle
Journal:  Vet Immunol Immunopathol       Date:  2016-04-19       Impact factor: 2.046

7.  Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.

Authors:  Stephen R Goding; Shaohong Yu; Lisa M Bailey; Michael T Lotze; Per H Basse
Journal:  Clin Immunol       Date:  2016-07-01       Impact factor: 3.969

8.  Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer.

Authors:  Cong-Jun Wang; Chao Wang; Jiang Han; Yong-Kun Wang; Lin Tang; Dong-Wei Shen; Yi Zhao; Rong-Hua Xu; Hui Zhang
Journal:  Mol Biol Rep       Date:  2013-10-18       Impact factor: 2.316

9.  Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus.

Authors:  Aura Muntasell; Marcel Costa-Garcia; Andrea Vera; Noemí Marina-Garcia; Carsten J Kirschning; Miguel López-Botet
Journal:  Front Immunol       Date:  2013-02-21       Impact factor: 7.561

10.  TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells.

Authors:  Chwee Ming Lim; Ryan Stephenson; Andres M Salazar; Robert L Ferris
Journal:  Oncoimmunology       Date:  2013-04-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.